Innate immunity may help limit cancer growth

September 17, 2015
Innate immunity may help limit cancer growth

Cancer immunotherapy, a relatively new frontier in cancer treatment, works by enhancing the capacity of one's immune system to attack cancer cells. To date, this field has focused on developing cancer vaccines or engineering specialized cells called lymphocytes capable of binding specific proteins produced by cancer cells but not by normal cells.

Now, a new study published in the journal Immunity and led by Dr. Maya Saleh, who is a William Dawson Scholar and Associate Professor in the Department of Medicine at McGill's Faculty of Medicine , demonstrates that our body's innate immune system can detect the presence of cancer spread and limit its growth.

"Until now, the focus has been on finding ways to stimulate adaptive, or specific, immunity to reject tumors," says Saleh, who is also Director, Inflammation and Cancer Program at McGill. "In contrast to this highly specialized form of immunity that is potentially patient- and cancer- specific, our findings show that innate immunity that broadly surveys tissues for the presence of 'danger' signals such as those produced in the cancer environment can also be harnessed for a more general cancer immunotherapy."

Using mice that lack components of the innate immune system, the researchers found that spread of colorectal cancer to the liver was more aggressive than in mice that have an intact immune system. This suggested that innate immunity keeps cancer spread under check. The team was further able to identify the sensor (Nlrp3) and its effector cytokine (IL-18) that activates the ability of one's to attack the tumor.

By identifying the nature of the innate sensor and the mechanism by which this factor orchestrates tumor killing, the findings could have important implications for the further development of , enabling potential therapeutic strategies that could harness this pathway to elicit tumor killing.

Explore further: 'Eat me' signal whets appetites for tumor-devouring dendritic cells

More information: "The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity." DOI: dx.doi.org/10.1016/j.immuni.2015.08.013

Related Stories

'Eat me' signal whets appetites for tumor-devouring dendritic cells

August 31, 2015
By changing the mouse model they use to study how the immune system responds to cancer, a team of researchers hopes to shift the focus for one emerging form of cancer immunotherapy back to the standard approach—relying ...

Inhibited Tyk2 retains anti-cancer activity

September 11, 2015
Tyrosine kinase 2 (Tyk2) is an enzyme involved in intracellular signalling and has an important role in activating the immune system. But enzymatically active Tyk2 can also promote excessive immune reactions and growth of ...

Aspirin could hold the key to supercharged cancer immunotherapy

September 3, 2015
Giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment, according to new research published in the journal Cell today (Thursday).

Switched before birth: Study shows protein creates tumor-fighting cells

September 14, 2015
Revealing a biological combat strategy worthy of a five-star general, researchers from Houston Methodist Hospital, University of Chicago and Cornell University have shown how a cell surface receptor—a specialized protein ...

The future of precision immunology

January 30, 2015
In his State of the Union address, President Obama announced a new precision medicine initiative to work on finding a cure for cancer and other diseases. Howard L. Kaufman, a leading immunotherapy expert from Rutgers Cancer ...

Stimulating both major branches of the immune system halts tumor growth more effectively

April 14, 2015
The human immune system is poised to spring into action at the first sign of a foreign invader, but it often fails to eliminate tumors that arise from the body's own cells. Cancer biologists hope to harness that untapped ...

Recommended for you

Early trials show potential for treating hay fever with grass protein fragments

October 13, 2017
Protein fragments taken from grass can help protect hay fever patients from allergic reactions to pollen grains.

Researchers find mechanism for precise targeting of the immune response

October 13, 2017
The immune system checks the health of cells by examining a kind of molecular passport. Sometimes, cells present the wrong passport, which can lead to autoimmune diseases, chronic inflammations or cancer. Scientists of the ...

Enzyme behind immune cell response revealed

October 12, 2017
Monash University researchers have revealed the role played by an enzyme that is pivotal to the process of clearing infection in the body. Moreover, they suggest that the enzyme may be a potential target for drug development ...

Calcium lets T cells use sugar to multiply and fight infection

October 11, 2017
A calcium signal controls whether immune cells can use the nutrients needed to fuel their multiplication into a cellular army designed to fight invading viruses.

New genetic clue to peanut allergy

October 11, 2017
Canadian researchers have pinpointed a new gene associated with peanut allergy, offering further evidence that genes play a role in the development of food allergies and opening the door to future research, improved diagnostics ...

Novel immune cells control neurons responsible for fat breakdown

October 9, 2017
The biological causes underlying obesity have been under intense scrutiny, with studies suggesting a link between the nervous and the immune systems. Now, in a breakthrough study to be published in Nature Medicine on 9 October, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.